{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T03:55:47Z","timestamp":1771991747890,"version":"3.50.1"},"reference-count":43,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T00:00:00Z","timestamp":1740182400000},"content-version":"unspecified","delay-in-days":21,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["GNT2008071"],"award-info":[{"award-number":["GNT2008071"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2025,2,5]]},"published-print":{"date-parts":[[2025,2]]},"abstract":"<jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>Penicillin allergy labels (PALs) are reported in 1 in 10 hospitalised patients globally and associated with inferior patient, hospital and microbiological outcomes; however, the majority are incorrect and should be removed. Direct oral penicillin challenge has been demonstrated to be a safe and effective method for the removal of PALs. However, the question of whether a single dose is sufficient to ascertain true allergy status remains unanswered, with some studies suggesting that extended challenges of 3 or more days are superior for the exclusion of delayed immune reactions. The aim of the PROSPECTOR studies was to determine the feasibility (PROSPECTOR-1) of a definitive trial (PROSPECTOR-2) to evaluate the safety and effectiveness of prolonged oral challenge (ie, 5\u2009days) versus single-dose oral challenge in patients with a delayed or unknown penicillin allergy phenotype (PROSPECTOR-2).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods and analysis<\/jats:title>\n                  <jats:p>A pair of double-blind two-arm parallel placebo-controlled trials will be undertaken<jats:bold>\u2014PRO<\/jats:bold>longed versus <jats:bold>S<\/jats:bold>ingle dose in <jats:bold>PE<\/jats:bold>nicillin oral <jats:bold>C<\/jats:bold>hallenge <jats:bold>T<\/jats:bold>esting double-blind parallel group randomised placebo-c<jats:bold>O<\/jats:bold>ntrolled t<jats:bold>R<\/jats:bold>ial (PROSPECTOR Studies). Patients with a reported delayed or unknown timing penicillin allergy who have passed a supervised single-dose oral amoxicillin challenge (with or without prior skin testing\/single or split dose) will be recruited. Informed patient consent will be granted for sites to recruit patients and collect routine clinical data. PROSPECTOR-1 will assess the safety and feasibility of a placebo-controlled trial for single-dose amoxicillin challenge versus 5-day prolonged oral challenge. PROSPECTOR-2 will assess the superiority of the 5-day prolonged oral challenge compared with single-dose amoxicillin challenge in excluding a delayed immune reaction. PROSPECTOR-2 will commence immediately post completion of PROSPECTOR-1 in a vanguard design, with adjustments to the projected sample size for superiority made following completion of PROSPECTOR-1. PROSPECTOR-2 will commence recruitment immediately following closure of PROSPECTOR-1; however, data from each trial will be analysed separately.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Ethics and dissemination<\/jats:title>\n                  <jats:p>These studies were reviewed and approved by the Austin Health Human Research Ethics Committee (PROSPECTOR-1: HREC\/99740\/Austin-2023 and PROSPECTOR-2: HREC\/109785\/Austin-2024). The results will be published in peer-reviewed journals and presented at relevant conferences.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Trial registration number<\/jats:title>\n                  <jats:p>PROSPECTOR-1: ACTRN12623001242617 and PROSPECTOR-2: ACTRN12624001107516.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjopen-2024-094712","type":"journal-article","created":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T22:36:17Z","timestamp":1740263777000},"page":"e094712","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":3,"title":["Prolonged versus single dose in penicillin oral challenge testing: protocols for a pilot and definitive randomised controlled trial (PROSPECTOR studies)"],"prefix":"10.1136","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1357-4666","authenticated-orcid":false,"given":"Irvin","family":"Ng","sequence":"first","affiliation":[{"name":"Infectious Diseases, The Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia"},{"name":"Infectious Diseases and Immunology, Austin Health, Heidelberg, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0469-5666","authenticated-orcid":false,"given":"Fiona","family":"James","sequence":"additional","affiliation":[{"name":"Infectious Diseases, The Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia"},{"name":"Infectious Diseases and Immunology, Austin Health, Heidelberg, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Copaescu","sequence":"additional","affiliation":[{"name":"Infectious Diseases, The Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia"},{"name":"Infectious Diseases and Immunology, Austin Health, Heidelberg, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Vogrin","sequence":"additional","affiliation":[{"name":"Infectious Diseases, The Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia"},{"name":"Infectious Diseases and Immunology, Austin Health, Heidelberg, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elise","family":"Mitri","sequence":"additional","affiliation":[{"name":"Infectious Diseases, The Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia"},{"name":"Infectious Diseases and Immunology, Austin Health, Heidelberg, Victoria, Australia"},{"name":"National Allergy Centre of Excellence, Parkville, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morgan","family":"Rose","sequence":"additional","affiliation":[{"name":"Infectious Diseases, The Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia"},{"name":"Infectious Diseases and Immunology, Austin Health, Heidelberg, Victoria, Australia"},{"name":"Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Sullivan","sequence":"additional","affiliation":[{"name":"Infectious Diseases, St George Hospital, Kogarah, New South Wales, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Lane","sequence":"additional","affiliation":[{"name":"Royal Brisbane and Women\u2019s Hospital, Herston, Queensland, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy","family":"Legg","sequence":"additional","affiliation":[{"name":"Pharmacy Department, Royal Brisbane and Women\u2019s Hospital, Herston, Queensland, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jack","family":"Godsell","sequence":"additional","affiliation":[{"name":"Infectious Diseases and Immunology, Austin Health, Heidelberg, Victoria, Australia"},{"name":"Allergy and Immunology, The Royal Melbourne Hospital, Parkville, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suran","family":"Fernando","sequence":"additional","affiliation":[{"name":"Clinical Immunology and Allergy, Royal North Shore Hospital, St Leonards, New South Wales, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lene Heise","family":"Garvey","sequence":"additional","affiliation":[{"name":"University of Copenhagen, Kobenhavn, Region Hovedstaden, Denmark"},{"name":"Allergy Clinic, Department of Dermatology and Allergy, Herlev and Gentofte Hospital, Gentofte, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vito","family":"Sabato","sequence":"additional","affiliation":[{"name":"Department of Immunology, Allergology and Rheumatology, University of Antwerp, Antwerpen, Belgium"},{"name":"Department of Immunology, Allergology and Rheumatology, University Hospital Antwerp, Edegem, Antwerp, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9155-9162","authenticated-orcid":false,"given":"Philip","family":"Li","sequence":"additional","affiliation":[{"name":"Division of Rheumatology and Clinical Immunology, Department of Medicine, Hong Kong University, Hong Kong, Hong Kong"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2658-0723","authenticated-orcid":false,"given":"Jonathan Grant","family":"Peter","sequence":"additional","affiliation":[{"name":"Division of Allergy and Immunology, Department of Medicine, University of Cape Town, Cape Town, South Africa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5111-6367","authenticated-orcid":false,"given":"Jason","family":"Trubiano","sequence":"additional","affiliation":[{"name":"Infectious Diseases, The Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia"},{"name":"Infectious Diseases and Immunology, Austin Health, Heidelberg, Victoria, Australia"},{"name":"National Allergy Centre of Excellence, Parkville, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2025,2,22]]},"reference":[{"key":"2025101811380688000_15.2.e094712.1","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-015-1303-3","article-title":"The prevalence and impact of antimicrobial allergies and adverse drug reactions at an Australian tertiary centre","volume":"15","author":"Trubiano","year":"2015","journal-title":"BMC Infect Dis"},{"key":"2025101811380688000_15.2.e094712.2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkw008"},{"key":"2025101811380688000_15.2.e094712.3","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jaip.2013.01.006","article-title":"Treatment of patients with a history of penicillin allergy in a large tertiary-care academic hospital","volume":"1","author":"Picard","year":"2013","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2025101811380688000_15.2.e094712.4","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-7843.2006.pto_230.x"},{"key":"2025101811380688000_15.2.e094712.5","doi-asserted-by":"crossref","DOI":"10.1093\/jacamr\/dlad015","article-title":"Low self-reported penicillin allergy in South Africa-implications for global public health response","volume":"5","author":"Day","year":"2023","journal-title":"JAC Antimicrob Resist"},{"key":"2025101811380688000_15.2.e094712.6","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.4199","article-title":"Prevalence, Incidence, and Sensitization Profile of \u03b2-lactam Antibiotic Allergy in Hong Kong","volume":"3","author":"Li","year":"2020","journal-title":"JAMA Netw Open"},{"key":"2025101811380688000_15.2.e094712.7","doi-asserted-by":"crossref","first-page":"469","DOI":"10.5694\/mja17.00487","article-title":"How antibiotic allergy labels may be harming our most vulnerable patients","volume":"208","author":"Trubiano","year":"2018","journal-title":"Med J Aust"},{"key":"2025101811380688000_15.2.e094712.8","doi-asserted-by":"crossref","first-page":"192","DOI":"10.12809\/hkmj208716","article-title":"Epidemiology and outcomes of geriatric and non-geriatric patients with drug allergy labels in Hong Kong","volume":"27","author":"Li","year":"2021","journal-title":"Hong Kong Med J"},{"key":"2025101811380688000_15.2.e094712.9","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics10110918","article-title":"Prevalence and Impact of Reported Drug Allergies among Rheumatology Patients","volume":"10","author":"Chan","year":"2020","journal-title":"Diagnostics (Basel)"},{"key":"2025101811380688000_15.2.e094712.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2013.09.021"},{"key":"2025101811380688000_15.2.e094712.11","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw462"},{"key":"2025101811380688000_15.2.e094712.12","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.k2400","article-title":"Risk of meticillin resistant Staphylococcus aureus and Clostridium difficile in patients with a documented penicillin allergy: population based matched cohort study","volume":"361","author":"Blumenthal","year":"2018","journal-title":"BMJ"},{"key":"2025101811380688000_15.2.e094712.13","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix794"},{"key":"2025101811380688000_15.2.e094712.14","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1111\/imj.13223","article-title":"The revolving door: antibiotic allergy labelling in a tertiary care centre","volume":"46","author":"Knezevic","year":"2016","journal-title":"Intern Med J"},{"key":"2025101811380688000_15.2.e094712.15","doi-asserted-by":"crossref","DOI":"10.1186\/s13756-015-0063-6","article-title":"The impact of antimicrobial allergy labels on antimicrobial usage in cancer patients","volume":"4","author":"Trubiano","year":"2015","journal-title":"Antimicrob Resist Infect Control"},{"key":"2025101811380688000_15.2.e094712.16","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1001\/jamainternmed.2023.2986","article-title":"Efficacy of a Clinical Decision Rule to Enable Direct Oral Challenge in Patients With Low-Risk Penicillin Allergy: The PALACE Randomized Clinical Trial","volume":"183","author":"Copaescu","year":"2023","journal-title":"JAMA Intern Med"},{"key":"2025101811380688000_15.2.e094712.17","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix244"},{"key":"2025101811380688000_15.2.e094712.18","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.jaip.2022.08.052","article-title":"Comparative Effectiveness, Safety, and Real-World Outcomes of a Nurse-Led, Protocol-Driven Penicillin Allergy Evaluation From the Hong Kong Drug Allergy Delabelling Initiative (HK-DADI)","volume":"11","author":"Kan","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2025101811380688000_15.2.e094712.19","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1016\/j.jaip.2024.04.010","article-title":"Prospective, Multicenter, Head-to-Head Comparison Between Allergists Versus Nonallergists in Low-Risk Penicillin Allergy Delabeling: Effectiveness, Safety, and Quality of Life (HK-DADI2)","volume":"12","author":"Wong","year":"2024","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2025101811380688000_15.2.e094712.20","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.idc.2023.06.005","article-title":"Penicillin Allergy Impact and Management","volume":"37","author":"Wrenn","year":"2023","journal-title":"Infect Dis Clin North Am"},{"key":"2025101811380688000_15.2.e094712.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2022.08.028"},{"key":"2025101811380688000_15.2.e094712.22","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/all.15996","article-title":"EAACI\/ENDA position paper on drug provocation testing","volume":"79","author":"Barbaud","year":"2024","journal-title":"Allergy"},{"key":"2025101811380688000_15.2.e094712.23","doi-asserted-by":"crossref","first-page":"307","DOI":"10.2340\/00015555-1254","article-title":"One-week oral challenge with penicillin in diagnosis of penicillin allergy","volume":"92","author":"Hjortlund","year":"2012","journal-title":"Acta Derm Venereol"},{"key":"2025101811380688000_15.2.e094712.24","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1111\/all.12195","article-title":"Diagnosis of penicillin allergy revisited: the value of case history, skin testing, specific IgE and prolonged challenge","volume":"68","author":"Hjortlund","year":"2013","journal-title":"Allergy"},{"key":"2025101811380688000_15.2.e094712.25","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.jaip.2014.11.001","article-title":"Amoxicillin allergy in children: five-day drug provocation test in the diagnosis of nonimmediate reactions","volume":"3","author":"Mori","year":"2015","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2025101811380688000_15.2.e094712.26","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.anai.2016.01.018","article-title":"Impact of an extended challenge on the effectiveness of \u03b2-lactam hypersensitivity investigation","volume":"116","author":"Ratzon","year":"2016","journal-title":"Ann Allergy Asthma Immunol"},{"key":"2025101811380688000_15.2.e094712.27","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1016\/j.jaip.2017.02.024","article-title":"The Importance of Prolonged Provocation in Drug Allergy - Results From a Danish Allergy Clinic","volume":"5","author":"Fransson","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2025101811380688000_15.2.e094712.28","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/pai.12826","article-title":"Non-immediate-reading skin tests and prolonged challenges in non-immediate hypersensitivity to beta-lactams in children","volume":"29","author":"Lezmi","year":"2018","journal-title":"Pediatr Allergy Immunol"},{"key":"2025101811380688000_15.2.e094712.29","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1159\/000320384","article-title":"Full-course drug challenge test in the diagnosis of delayed allergic reactions to penicillin","volume":"155","author":"Borch","year":"2011","journal-title":"Int Arch Allergy Immunol"},{"key":"2025101811380688000_15.2.e094712.30","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1159\/000521708","article-title":"Safe De-Labeling of Patients at Low Risk of Penicillin Allergy in Denmark","volume":"183","author":"Fransson","year":"2022","journal-title":"Int Arch Allergy Immunol"},{"key":"2025101811380688000_15.2.e094712.31","unstructured":"Boysen J , Garvey L . Retrospective evaluation of the pen-fast tool in patients undergoing prolonged drug provocation. 2023."},{"key":"2025101811380688000_15.2.e094712.32","doi-asserted-by":"publisher","DOI":"10.1016\/0091-6749(84)90487-1"},{"key":"2025101811380688000_15.2.e094712.33","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(98)70499-8"},{"key":"2025101811380688000_15.2.e094712.34","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1001\/archinte.162.7.822","article-title":"Lack of penicillin resensitization in patients with a history of penicillin allergy after receiving repeated penicillin courses","volume":"162","author":"Solensky","year":"2002","journal-title":"Arch Intern Med"},{"key":"2025101811380688000_15.2.e094712.35","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.jaip.2017.06.014","article-title":"Risk of Allergic Reactions to Recurrent Intravenous Penicillin Administration in Penicillin Skin Test Negative Patients","volume":"6","author":"Dorman","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2025101811380688000_15.2.e094712.36","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jaip.2018.06.023","article-title":"Provocation Tests in Nonimmediate Hypersensitivity Reactions to \u03b2-Lactam Antibiotics in Children: Are Extended Challenges Needed?","volume":"7","author":"Garc\u00eda Rodr\u00edguez","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2025101811380688000_15.2.e094712.37","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1001\/jamainternmed.2020.0403","article-title":"Development and Validation of a Penicillin Allergy Clinical Decision Rule","volume":"180","author":"Trubiano","year":"2020","journal-title":"JAMA Intern Med"},{"key":"2025101811380688000_15.2.e094712.38","doi-asserted-by":"crossref","DOI":"10.1186\/1745-6215-15-264","article-title":"Sample size requirements to estimate key design parameters from external pilot randomised controlled trials: a simulation study","volume":"15","author":"Teare","year":"2014","journal-title":"Trials"},{"key":"2025101811380688000_15.2.e094712.39","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1080\/14787210.2023.2296068","article-title":"Low-risk penicillin allergy delabeling: a scoping review of direct oral challenge practice, implementation, and multi-disciplinary approaches","volume":"22","author":"Mitri","year":"2024","journal-title":"Expert Rev Anti Infect Ther"},{"key":"2025101811380688000_15.2.e094712.40","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(17)30325-0"},{"key":"2025101811380688000_15.2.e094712.41","doi-asserted-by":"crossref","DOI":"10.1186\/s40814-016-0105-8","article-title":"CONSORT 2010 statement: extension to randomised pilot and feasibility trials","volume":"2","author":"Eldridge","year":"2016","journal-title":"Pilot Feasibility Stud"},{"key":"2025101811380688000_15.2.e094712.42","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-152-11-201006010-00232"},{"key":"2025101811380688000_15.2.e094712.43","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.anai.2010.12.014","article-title":"Development and validation of the Drug Hypersensitivity Quality of Life Questionnaire","volume":"106","author":"Baiardini","year":"2011","journal-title":"Ann Allergy Asthma Immunol"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2024-094712","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T18:38:15Z","timestamp":1760812695000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2024-094712"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":43,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,2,22]]},"published-print":{"date-parts":[[2025,2]]}},"alternative-id":["10.1136\/bmjopen-2024-094712"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2024-094712","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2]]}}}